225 related articles for article (PubMed ID: 28493438)
1. Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy.
Nakayama T; Wu J; Galvin-Parton P; Weiss J; Andriola MR; Hill RS; Vaughan DJ; El-Quessny M; Barry BJ; Partlow JN; Barkovich AJ; Ling J; Mochida GH
Hum Mutat; 2017 Oct; 38(10):1348-1354. PubMed ID: 28493438
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.
Simons C; Griffin LB; Helman G; Golas G; Pizzino A; Bloom M; Murphy JL; Crawford J; Evans SH; Topper S; Whitehead MT; Schreiber JM; Chapman KA; Tifft C; Lu KB; Gamper H; Shigematsu M; Taft RJ; Antonellis A; Hou YM; Vanderver A
Am J Hum Genet; 2015 Apr; 96(4):675-81. PubMed ID: 25817015
[TBL] [Abstract][Full Text] [Related]
3. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
[TBL] [Abstract][Full Text] [Related]
4. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F
Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830
[TBL] [Abstract][Full Text] [Related]
5. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R
Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102
[TBL] [Abstract][Full Text] [Related]
6. WARS1 and SARS1: Two tRNA synthetases implicated in autosomal recessive microcephaly.
Bögershausen N; Krawczyk HE; Jamra RA; Lin SJ; Yigit G; Hüning I; Polo AM; Vona B; Huang K; Schmidt J; Altmüller J; Luppe J; Platzer K; Dörgeloh BB; Busche A; Biskup S; Mendes MI; Smith DEC; Salomons GS; Zibat A; Bültmann E; Nürnberg P; Spielmann M; Lemke JR; Li Y; Zenker M; Varshney GK; Hillen HS; Kratz CP; Wollnik B
Hum Mutat; 2022 Oct; 43(10):1454-1471. PubMed ID: 35790048
[TBL] [Abstract][Full Text] [Related]
7. CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells.
Blocquel D; Sun L; Matuszek Z; Li S; Weber T; Kuhle B; Kooi G; Wei N; Baets J; Pan T; Schimmel P; Yang XL
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19440-19448. PubMed ID: 31501329
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
Wei N; Zhang Q; Yang XL
J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
[TBL] [Abstract][Full Text] [Related]
9. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.
Zhang X; Ling J; Barcia G; Jing L; Wu J; Barry BJ; Mochida GH; Hill RS; Weimer JM; Stein Q; Poduri A; Partlow JN; Ville D; Dulac O; Yu TW; Lam AT; Servattalab S; Rodriguez J; Boddaert N; Munnich A; Colleaux L; Zon LI; Söll D; Walsh CA; Nabbout R
Am J Hum Genet; 2014 Apr; 94(4):547-58. PubMed ID: 24656866
[TBL] [Abstract][Full Text] [Related]
10. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS.
Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480
[TBL] [Abstract][Full Text] [Related]
11. Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.
Stephen J; Nampoothiri S; Banerjee A; Tolman NJ; Penninger JM; Elling U; Agu CA; Burke JD; Devadathan K; Kannan R; Huang Y; Steinbach PJ; Martinis SA; Gahl WA; Malicdan MCV
Hum Genet; 2018 Apr; 137(4):293-303. PubMed ID: 29691655
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy.
Kodera H; Osaka H; Iai M; Aida N; Yamashita A; Tsurusaki Y; Nakashima M; Miyake N; Saitsu H; Matsumoto N
J Hum Genet; 2015 Feb; 60(2):97-101. PubMed ID: 25471517
[TBL] [Abstract][Full Text] [Related]
13. A novel AARS mutation in a family with dominant myeloneuropathy.
Motley WW; Griffin LB; Mademan I; Baets J; De Vriendt E; De Jonghe P; Antonellis A; Jordanova A; Scherer SS
Neurology; 2015 May; 84(20):2040-7. PubMed ID: 25904691
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
[TBL] [Abstract][Full Text] [Related]
15. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
[TBL] [Abstract][Full Text] [Related]
16. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.
Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E
J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581
[TBL] [Abstract][Full Text] [Related]
17. Coordination between aminoacylation and editing to protect against proteotoxicity.
Zhang H; Murphy P; Yu J; Lee S; Tsai FTF; van Hoof A; Ling J
Nucleic Acids Res; 2023 Oct; 51(19):10606-10618. PubMed ID: 37742077
[TBL] [Abstract][Full Text] [Related]
18. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
[TBL] [Abstract][Full Text] [Related]
19. Congenital Visual Impairment and Progressive Microcephaly Due to Lysyl-Transfer Ribonucleic Acid (RNA) Synthetase (KARS) Mutations: The Expanding Phenotype of Aminoacyl-Transfer RNA Synthetase Mutations in Human Disease.
McMillan HJ; Humphreys P; Smith A; Schwartzentruber J; Chakraborty P; Bulman DE; Beaulieu CL; ; Majewski J; Boycott KM; Geraghty MT
J Child Neurol; 2015 Jul; 30(8):1037-43. PubMed ID: 25330800
[TBL] [Abstract][Full Text] [Related]
20. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy.
Friedman J; Smith DE; Issa MY; Stanley V; Wang R; Mendes MI; Wright MS; Wigby K; Hildreth A; Crawford JR; Koehler AE; Chowdhury S; Nahas S; Zhai L; Xu Z; Lo WS; James KN; Musaev D; Accogli A; Guerrero K; Tran LT; Omar TEI; Ben-Omran T; Dimmock D; Kingsmore SF; Salomons GS; Zaki MS; Bernard G; Gleeson JG
Nat Commun; 2019 Feb; 10(1):707. PubMed ID: 30755602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
